Trelagliptin Succinate is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes by promoting insulin secretion and reducing glucagon levels. Laboratories utilize high-quality… Read more
Trelagliptin Succinate is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes by promoting insulin secretion and reducing glucagon levels. Laboratories utilize high-quality reference standards of Trelagliptin Succinate to support rigorous quality control and pharmaceutical research. This collection includes the active pharmaceutical ingredient, critical impurity standards, and the racemic mixture, which are essential for precise impurity profiling and regulatory compliance. Additionally, researchers rely on stable isotope labelled compounds to serve as internal standards for mass spectrometry and method validation, ensuring accurate quantification in complex biological matrices. These materials are fundamental for stability testing and analytical method development, enabling pharmaceutical scientists to maintain the required standards for purity, safety, and efficacy throughout the drug development lifecycle.